SCHEMBL1743874

SCHEMBL1743874

CC(I)CCCl

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11364332 0.84
SCHEMBL12294775 0.74
SCHEMBL1001858 0.74
SCHEMBL17635568 0.72
SCHEMBL3774555 0.72
SCHEMBL9576005 0.69
SCHEMBL3383991 0.69
SCHEMBL11622386 0.69
SCHEMBL352000 0.69
SCHEMBL14960497 0.69

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101602756-B Novel compunds, pharmaceutical compositions containing same, and methods of use for same FASGEN INC US 2014-11-12 CN disclosed
EP-2386551-A1 Novel compounds, pharmaceutical compositions containing same, and methods of use for same Fasgen Inc. (US) 2011-11-16 EP disclosed
EP-2386550-A1 Novel compounds, pharmaceutical compositions containing same, and methods of use for same Fasgen Inc. (US) 2011-11-16 EP disclosed
US-D647106-S1 Display module for an electronic device APPLE INC. (US) 2011-10-18 US disclosed
US-8038089-B2 Leader member in recording tape cartridge, manufacturing method thereof, and recording tape cartridge FUJIFILM CORPORATION (JP) 2011-10-18 US disclosed
US-20100120901-A1 NOVEL COMPOUNDS, PHARMACEUTICAL COMPOSITIONS CONTAINING SAME, AND METHODS OF USE FOR SAME FASGEN,INC (US) 2010-05-13 US disclosed
US-7649012-B2 Compounds, pharmaceutical compositions containing same, and methods of use for same FASGEN, INC. (US) 2010-01-19 US disclosed
CN-101602756-A New compound, the pharmaceutical composition that contains this compound and this application of compound method FASGEN INC (US) 2009-12-16 CN disclosed
CN-100513404-C Novel compounds, pharmaceutical compositions containing the same and methods of use of the same FASGEN INC THE JOHNS HOPKINS U (US) 2009-07-15 CN disclosed
EP-1539730-A4 NOVEL COMPUNDS, PHARMACEUTICAL COMPOSITIONS CONTAINING SAME, AND METHODS OF USE FOR SAME FASGEN INC (US) 2007-03-28 EP disclosed
US-20060247302-A1 Novel compounds, pharmaceutical compositions containing same, and methods of use for same FASGEN, INC. (US) 2006-11-02 US disclosed
CN-1675192-A Novel compounds, pharmaceutical compositions containing the same and methods of use of the same FASGEN INC (US) 2005-09-28 CN disclosed
EP-1539730-A1 NOVEL COMPUNDS, PHARMACEUTICAL COMPOSITIONS CONTAINING SAME, AND METHODS OF USE FOR SAME Fasgen Inc. (US) 2005-06-15 EP disclosed
WO-2004005277-A1 NOVEL COMPUNDS, PHARMACEUTICAL COMPOSITIONS CONTAINING SAME, AND METHODS OF USE FOR SAME FASGEN, INC. (US) 2004-01-15 WO disclosed